Latest News
-
Profitability of Infused Biologics for Hospitals and Physician Practices: A Case Study of Keytruda
Read Article: Profitability of Infused Biologics for Hospitals and Physician Practices: A Case Study of KeytrudaA recent Health Affairs study examines insurer spending and provider margins associated with Keytruda, highlighting significant differences among 340B-eligible hospitals, noneligible hospitals, and community-based physician practices. The findings offer important insight into how the site of cancer care can affect…
-
Athena CEO Dr. Harsha Vyas Featured in Oncology News Central
Read Article: Athena CEO Dr. Harsha Vyas Featured in Oncology News CentralThe Federal Trade Commission (FTC) has announced a landmark settlement with one of the nation’s largest pharmacy benefit managers, Express Scripts, aimed at significantly lowering prescription drug costs for American patients.
-
Harsha Vyas, MD, FACP, Featured in Oncology News Central on Oncology Practice Consolidation
Read Article: Harsha Vyas, MD, FACP, Featured in Oncology News Central on Oncology Practice ConsolidationThe Federal Trade Commission (FTC) has announced a landmark settlement with one of the nation’s largest pharmacy benefit managers, Express Scripts, aimed at significantly lowering prescription drug costs for American patients.
-
The Athena Annual Conference 2026
Read Article: The Athena Annual Conference 2026The Federal Trade Commission (FTC) has announced a landmark settlement with one of the nation’s largest pharmacy benefit managers, Express Scripts, aimed at significantly lowering prescription drug costs for American patients.
-
“The Dying Breed of Community Oncology” Needs Defenders
Read Article: “The Dying Breed of Community Oncology” Needs DefendersThe Federal Trade Commission (FTC) has announced a landmark settlement with one of the nation’s largest pharmacy benefit managers, Express Scripts, aimed at significantly lowering prescription drug costs for American patients.
